March 2025 Life Sciences Update

Austin

MARKETS CONTENTS

Market Summary

Public & Private Funding (2024)

• Austin, with its strong focus on technology and innovation, has naturally fostered a partnership with the growing life sciences sector. The city’s creative and entrepreneurial environment is a magnet for collaboration between tech companies, research institutions, talent and funding sources. • Austin’s life sciences industry has evolved into a well -rounded segment, with over 300 companies in the region and a workforce of nearly 21,000. There is a primary focus on the highest growth segments and research areas, which include biologics, medical devices, diagnostics, pharmaceuticals and contract research. • With more than 20 area colleges, universities and institutions providing life sciences and healthcare-related programs, Austin boasts one of the most educated populations in the United States. The University of Texas at Austin, a Tier 1 research university, is the most notable with its highly ranked College of Pharmacy. More than half of UT's research is dedicated to life sciences. • The Austin Innovation District, anchored by UT Austin, Dell Medical School and the Dell Seton Medical Center, will be an epicenter for life sciences research and development for both existing and startup biotech companies. • Menlo Park-based BillionToOne, a next-generation molecular diagnostics company, recently announced plans to expand to Austin, adding an estimated 1,000 jobs. This move strengthens Austin's growing life sciences sector and reinforces the city's status as a hub for innovation.

Company

Deal Type

Completed

VC Round

$ Raised (MM)

Fast Lab Stats

Colossal Laboratories & Biosciences

4.8 MSF Total Inventory 220,000 SF Under Construction 1.3 MSF Proposed 21.0K Total Life Sciences Employment 45.4% Life Sciences Employment 10-Year Growth Rate

Early Stage VC

Jul 2024

3rd Round

$162.6

Gameto

Early Stage VC

May 2024

3rd Round

$43.0

IntraBio

Later Stage VC

Mar 2024

4th Round

$40.3

Form Bio

Early Stage VC

Aug 2024

2nd Round

$34.0

Vironexis Biotherapeutics

Early Stage VC

Aug 2024

3rd Round

$26.0

MedScout

Early Stage VC

Jul 2024

4th Round

$10.0

Nuclein

Later Stage VC

Aug 2024

4th Round

$8.8

Humanaut Health

Seed Round

May 2024

1st Round

$8.7

Nurocor

Later Stage VC

Oct 2024

2nd Round

$5.3

Funga

Seed Round

Dec 2024

2nd Round

$5.1

Representative Lease Transactions (2024)

Address

Size (SF) New/Renewal

Type

Quarter

Landlord

Company

7551 Metro Center Drive

200,000 Renewal

Research

Q2

Graymark Capital

Confidential

Representative Life Sciences Companies

Life Sciences Labor: Average Monthly Job Postings

Company

Type

450

Fast Lab Stats

ICU Medical

Research Facility

400

350

Pharmaceutical Product Development

Research Facility

300

HQ

Clinical Pathology Laboratories

250

Luminex Corp

HQ

200

Hanger

HQ

150

100

Agilent Technologies

Research Facility

50

Research Facility

Smith & Nephew

-

Allergan

Research Facility

2020 2021

2022 2023 2024

Natera

Research Facility

Hires Unique Postings

WuXi

HQ

Top NIH-Funded Institutions (2020-2024)

Bio Degree-Awarding Institutions, Metro Area

Annual Life Sciences Degree Completions 2013 1,632

$501M University of Texas at Austin $39M Dell Federal Systems L.P. $11M Bridgesource Medical Corporation

University of Texas at Austin

•

Austin Community College Texas A&M Health Science Center

• •

2023 3,162 Up 94%

Jeff Graves jeff.graves@cushwake.com Research Contributors

Sources: Cushman & Wakefield Research, CoStar, National Institutes of Health (NIH), Lightcast, Pitchbook

Cushman & Wakefield

74